The Unreasonable Math of Type 1 Diabetes

Re:The Unreasonable Math of Type 1 Diabetes by westoncb on Thursday February 17, 2022 @07:17PM (#30380657)

I wonder if there's any good reason to reduce my pessimism about it: I can't help but think there are such strong economic incentives against having a cure (vs ongoing treatment) that it's very unlikely to become available during my lifetime.

[ Parent | on HN ]

Re:The Unreasonable Math of Type 1 Diabetes by kelp on Thursday February 17, 2022 @09:51PM (#30381601)

I don't know much about medical research, but I've looked into some of these trials. They are generally being done by startups and not the established players who sell the diabetes management stuff.

So think disruptive tech. A new player comes into the market with something that obsoletes the old tech, and maybe destroys a whole market. But that new player makes their own money off it.

So yeah, maybe Tandem, Dexcom and Medtronic don't have a big incentive. But someone else can make some real money if they can find a cure or novel treatment that obsoletes all those others things.

[ Parent | on HN ]

Re:The Unreasonable Math of Type 1 Diabetes by R0b0t1 on Thursday February 17, 2022 @09:02PM (#30381322)

I don't want to feed your pessimism too much but I think the general culture of being too reserved with funding and testing is going to do more harm than that.

[ Parent | on HN ]